FMR1 and fragile X syndrome: The aim of the study was to evaluate if longer-term treatment with Bryostatin 1 would result in further improvement in FXS phenotypes including repetitive behaviour, hyperactivity and open field habituation, hippocampal dependent ADL and memory in Fmr1 KO2 mice.